MediWales
News & Opportunity
…ions that are useful, useable and rapidly updated. They’ll incorporate the latest evidence and newly recommended technologies to maximise uptake and access for patients. Drive the implementation of our guidance, forming key strategic partnerships to make sure it’s used. We’ll make sure it delivers improvements and contributes to reducing inequalities, with measures to routinely track adoption. Be scientific leaders, driving the research agenda and…
Member
News & Opportunity
…ncome and employment for life sciences businesses in Wales. Meanwhile, the latest export figures for Wales reveal the growing global influence of Welsh life sciences. The figures, published on 19 December 2022, and including data up to the third quarter of 2022, show significant growth in exports for the life sciences industry. Highlights: The OLS figures show income growth of Welsh life sciences businesses outperformed that of businesses in the r…
News & Opportunity
…nologies. AliveCor protects its customers with stringent data security and compliance practices, achieving HIPAA compliance and SOC2 Type 1 and Type 2 attestations. AliveCor is a privately-held company headquartered in Mountain View, Calif. “Consumer” or “Personal” ECGs are ECG devices available for direct sale to consumers. For more information, visit alivecor.com. References 1 NICE Medical Technologies Guidance. KardiaMobile for detecting atrial…
News & Opportunity
…Professor Evans set up and became director of the Haemostasis Biomedical Research Unit and research programme within Morriston’s Emergency Department. Nine years later it became the Welsh Centre for Emergency Medicine Research, officially opened by then-Health Minister Vaughan Gething. This too is a collaboration with Swansea University, with strong support from the School of Medicine, the Royal College of Emergency Medicine and Swansea Bay Univer…
News & Opportunity
…expect which will be available on its website. Cervical screening is not a test for cancer; it is a test for the virus that causes it. Human papillomavirus (HPV) is a very common virus that most people will have at some time during their life but only certain types of HPV cause cervical cancer. Since September 2018, CSW has routinely used a more sensitive cervical screening test which looks for the 14 high-risk types of HPV that cause 99.8% of cer…
News & Opportunity
…ons, as well as variants such as Delta and Omicron. InBio is measuring these T cell responses in healthy donors, as well as in immunocompromised individuals, deemed to be clinically vulnerable and most at risk from severe COVID-19 disease. Research Made Real! This test will be widely available to variety of end users, including researchers, clinicians, and government bodies. If you would like to know more or are interested in working with InBio, p…
News & Opportunity
…s to a digital system that’s available to all pharmacies across Wales. The Common Ailments Service supports community pharmacies to provide services for patients across Wales and aims to free up GP appointments for people with more complex needs. Under the scheme, free treatment and advice can be offered for 27 common conditions including sore throats, colic and chickenpox. It is part of the wider Choose Pharmacy service – a digital application de…
News & Opportunity
…blood test which can then lead to treatment getting underway sooner.” His latest study, which is expected to run until October, uses a technique called Raman spectroscopy to detect changes in blood samples related to lung cancer. If successful, it is expected to have a big impact on the diagnosis of lung cancer at a far earlier stage. The study has been made possible by funding of £45,000 by the Medical Research Council Impact Acceleration Accoun…